DE3787386D1 - In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung. - Google Patents

In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung.

Info

Publication number
DE3787386D1
DE3787386D1 DE87810103T DE3787386T DE3787386D1 DE 3787386 D1 DE3787386 D1 DE 3787386D1 DE 87810103 T DE87810103 T DE 87810103T DE 3787386 T DE3787386 T DE 3787386T DE 3787386 D1 DE3787386 D1 DE 3787386D1
Authority
DE
Germany
Prior art keywords
treatment
composition
estrogen insufficiency
estrogen
insufficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87810103T
Other languages
English (en)
Other versions
DE3787386T2 (de
Inventor
Roger Boissoneault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE3787386D1 publication Critical patent/DE3787386D1/de
Publication of DE3787386T2 publication Critical patent/DE3787386T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dental Preparations (AREA)
DE87810103T 1986-02-27 1987-02-23 In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung. Expired - Fee Related DE3787386T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83426386A 1986-02-27 1986-02-27

Publications (2)

Publication Number Publication Date
DE3787386D1 true DE3787386D1 (de) 1993-10-21
DE3787386T2 DE3787386T2 (de) 1994-05-05

Family

ID=25266516

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87810103T Expired - Fee Related DE3787386T2 (de) 1986-02-27 1987-02-23 In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung.

Country Status (12)

Country Link
EP (1) EP0235090B1 (de)
JP (1) JP2942560B2 (de)
AT (1) ATE94392T1 (de)
AU (1) AU599082B2 (de)
CA (1) CA1300017C (de)
DE (1) DE3787386T2 (de)
DK (1) DK174892B1 (de)
ES (1) ES2059403T3 (de)
HK (1) HK182795A (de)
MY (1) MY101855A (de)
NL (1) NL300004I1 (de)
ZA (1) ZA87332B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174724B1 (da) † 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
AU640112B2 (en) * 1989-11-03 1993-08-19 Warner-Lambert Company Estrogen and progestogen containing oral dosage forms
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor

Also Published As

Publication number Publication date
AU599082B2 (en) 1990-07-12
EP0235090B1 (de) 1993-09-15
DE3787386T2 (de) 1994-05-05
ZA87332B (en) 1987-08-26
MY101855A (en) 1992-01-31
DK99987A (da) 1987-08-28
ATE94392T1 (de) 1993-10-15
NL300004I1 (nl) 2000-04-03
AU6913087A (en) 1987-09-03
DK174892B1 (da) 2004-01-26
HK182795A (en) 1995-12-08
JP2942560B2 (ja) 1999-08-30
JPS62205024A (ja) 1987-09-09
EP0235090A1 (de) 1987-09-02
ES2059403T3 (es) 1994-11-16
DK99987D0 (da) 1987-02-26
CA1300017C (en) 1992-05-05

Similar Documents

Publication Publication Date Title
DE3689974D1 (de) Arzneimittel zur Behandlung von Emesis.
ATE38232T1 (de) Metallocene und photopolymerisierbare zusammensetzung, enthaltend diese metallocene.
DE3752141D1 (de) Mittel zur behandlung von neuropathie
PH23432A (en) Tetrahydronaphthaline and indane derivatives and pharmaceutical composition containing said compounds
IT1211936B (it) Chetoni triciclici,procedimento per prepararli e composizioni farmaceutiche che li contengono
HUT45252A (en) Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them as active components
EG18379A (en) Novel pharmacological compounds
DE3787386D1 (de) In der Behandlung von Östrogeninsuffizienz zu verwendende Zusammensetzung.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
DE3775192D1 (de) Zusatz von calciumverbindungen in der karbothermischen reduktion von kieselerde.
DE3781574D1 (de) Calixaren-derivate und die verwendung dieser verbindungen zur sequestrierung von metallen.
JPS5328133A (en) Novel compound having lipidddepleting activity in blood*process for preparation thereof and pharmaceutical composition containing these
HUT46930A (en) Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components
HUT43573A (en) Process for producing azolyl-cyclopropyl-ethanol derivatives and compositions containing them as active agents
JPS53149974A (en) Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same
DK464483A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel
DE3683286D1 (de) Anthrachinonverbindungen und fluessigkristallzusammensetzung, die diese enthalten.
DE58909244D1 (de) Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht.
DE3682155D1 (de) Fluessigkristall-alkoxycarbonyloxybenzoesaeurederivate und zusammensetzung.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
IT1197929B (it) Composizione perossidiche liquide
IE41296L (en) 2', 3'-DIHYDROESTRA-1, 3, 5(10)-TRIENO-(16Ó, 17Ó-b)¹FURAN-17ß-OLS.
DE3763141D1 (de) Pharmazeutische zusammensetzungen zur behandlung des charcot-syndroms.
IT1203976B (it) Derivati dell'ergolene, composizioni farmaceutiche che li contengono e procedimento per la preparazione dei medesimi
DE3481534D1 (de) Verteilung und dosieren von kraftstoff.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee